Hana Choi

发表

Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition

Ssang-Goo Cho, Bong-Woo Kim, Eung-Ryoung Lee, 2008, Cancer biology & therapy.

Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors

Dong-Wan Kim, D. Heo, Hana Choi, 2016, Cancer Immunology Research.

The dynamic nature of the coronavirus receptor, angiotensin-converting enzyme 2 (ACE2) in differentiating airway epithelia

Hana Choi, S. Caradonna, Vincent Manna, 2022, BBA Advances.

142 Contextual reprogramming of CAR T cells for the treatment of HER2-expressing cancers

F. Marincola, Hana Choi, Zhifen Yang, 2020, Journal for ImmunoTherapy of Cancer.

Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers

Lei S. Qi, F. Marincola, Hana Choi, 2020, Journal of translational medicine.

Fanconi anemia protein FANCD2 is activated by AICAR, a modulator of AMPK and cellular energy metabolism

Hana Choi, Yong‐Nyun Kim, Sunshin Kim, 2017, FEBS open bio.

Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy

Hana Choi, E. Shin, J. Her, 2018, Immune network.

Nanoscale, antigen encounter-dependent, IL-12 delivery by CAR T cells plus PD-L1 blockade for cancer treatment

Lei S. Qi, F. Marincola, Hana Choi, 2023, Journal of Translational Medicine.

Inhibition of Isorhamnetin on β-Catenin/Tcf Signaling and β-Catenin-Activated Melanogenesis

Hana Choi, Seyeon Park, Yunjoo Kim, 2013 .

Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers

Lei S. Qi, Dharmesh M. Patel, F. Marincola, 2021, Journal of Translational Medicine.

Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors

Dong-Wan Kim, D. Heo, Hana Choi, 2016, Cancer Immunology Research.